Cardiovascular Syst (CSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,390 | -1,977 | -1,792 | -2,564 | -815 |
| Depreciation Amortization | 2,090 | 994 | 4,135 | 2,932 | 1,940 |
| Accounts receivable | 561 | 1,056 | -5,809 | -5,064 | -2,460 |
| Other Working Capital | -6,198 | -4,736 | 5,397 | 6,423 | 5,743 |
| Other Operating Activity | 5,112 | 2,163 | 17,657 | 14,756 | 9,414 |
| Operating Cash Flow | $-825 | $-2,500 | $19,588 | $16,483 | $13,822 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 96 | 47 | 46 | 0 | 0 |
| PPE Investments | -1,269 | -569 | -981 | -841 | -481 |
| Purchase Sale Intangibles | -622 | -455 | -844 | -496 | -375 |
| Other Investing Activity | -479 | -455 | -844 | -496 | -375 |
| Investing Cash Flow | $-1,652 | $-977 | $-1,779 | $-1,337 | $-856 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 20,944 | 20,944 | N/A |
| Common Stock Issued | 1,898 | 306 | 8,517 | 6,402 | 5,675 |
| Other Financing Activity | 12 | 6 | 4 | 0 | 0 |
| Financing Cash Flow | $1,910 | $312 | $29,465 | $27,346 | $5,675 |
| Beginning Cash Position | 107,912 | 107,912 | 60,638 | 60,638 | 60,638 |
| End Cash Position | 107,345 | 104,747 | 107,912 | 103,130 | 79,279 |
| Net Cash Flow | $-567 | $-3,165 | $47,274 | $42,492 | $18,641 |
| Free Cash Flow | |||||
| Operating Cash Flow | -825 | -2,500 | 19,588 | 16,483 | 13,822 |
| Capital Expenditure | -1,269 | -569 | -981 | -841 | -481 |
| Free Cash Flow | -2,094 | -3,069 | 18,607 | 15,642 | 13,341 |